X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1670) 1670
azetidines - therapeutic use (1365) 1365
science & technology (1354) 1354
life sciences & biomedicine (1333) 1333
ezetimibe (1013) 1013
male (843) 843
anticholesteremic agents - therapeutic use (762) 762
female (687) 687
middle aged (558) 558
drug therapy, combination (449) 449
aged (427) 427
azetidines - administration & dosage (424) 424
azetidines - pharmacology (423) 423
pharmacology & pharmacy (412) 412
animals (405) 405
cholesterol, ldl - blood (400) 400
treatment outcome (391) 391
hypercholesterolemia - drug therapy (376) 376
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (367) 367
cardiovascular system & cardiology (360) 360
adult (340) 340
azetidines - adverse effects (322) 322
simvastatin - therapeutic use (315) 315
abridged index medicus (257) 257
cardiac & cardiovascular systems (252) 252
anticoagulants - therapeutic use (246) 246
cholesterol (246) 246
general & internal medicine (235) 235
medicine, general & internal (231) 231
benzylamines (228) 228
double-blind method (207) 207
anticholesteremic agents - administration & dosage (199) 199
risk factors (192) 192
statins (174) 174
dose-response relationship, drug (163) 163
peripheral vascular disease (158) 158
hypercholesterolemia (157) 157
randomized controlled trials as topic (157) 157
anticholesteremic agents - adverse effects (156) 156
azetidines - pharmacokinetics (156) 156
drug therapy (154) 154
anticholesteremic agents - pharmacology (153) 153
administration, oral (152) 152
clinical trials as topic (152) 152
hypercholesterolemia - blood (148) 148
simvastatin (146) 146
drug combinations (138) 138
lipids (138) 138
care and treatment (137) 137
low density lipoproteins (135) 135
thrombin - antagonists & inhibitors (125) 125
mice (124) 124
cardiovascular (122) 122
sulfonamides - therapeutic use (122) 122
aged, 80 and over (117) 117
research (117) 117
rats (114) 114
cholesterol - blood (113) 113
hypolipidemic agents - therapeutic use (113) 113
analysis (110) 110
atherosclerosis (108) 108
simvastatin - administration & dosage (107) 107
warfarin - therapeutic use (107) 107
medicine & public health (104) 104
benzylamines - therapeutic use (101) 101
cardiovascular diseases - prevention & control (101) 101
cholesterol, hdl - blood (101) 101
dyslipidemias - drug therapy (101) 101
time factors (101) 101
triglycerides - blood (101) 101
pyrroles - therapeutic use (100) 100
ximelagatran (100) 100
atorvastatin calcium (99) 99
cholesterol - metabolism (98) 98
stroke - prevention & control (97) 97
cardiovascular disease (96) 96
clinical trials (96) 96
adolescent (90) 90
antilipemic agents (89) 89
cholesterol, ldl - drug effects (89) 89
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (89) 89
anticoagulants - administration & dosage (87) 87
hyperlipidemias - drug therapy (87) 87
anticoagulants - adverse effects (84) 84
pharmacology/toxicology (84) 84
ezetimibe, simvastatin drug combination (82) 82
atrial fibrillation - drug therapy (81) 81
internal medicine (81) 81
heptanoic acids - therapeutic use (80) 80
thromboembolism - prevention & control (80) 80
anticoagulants (79) 79
lipids - blood (79) 79
niacin - therapeutic use (79) 79
intestinal absorption - drug effects (77) 77
medicine, research & experimental (76) 76
research & experimental medicine (76) 76
young adult (76) 76
simvastatin - adverse effects (75) 75
azetidines - chemistry (74) 74
venous thrombosis - prevention & control (73) 73
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1758) 1758
German (67) 67
French (31) 31
Spanish (19) 19
Hungarian (12) 12
Japanese (12) 12
Italian (10) 10
Russian (7) 7
Portuguese (5) 5
Turkish (5) 5
Polish (4) 4
Chinese (3) 3
Danish (3) 3
Dutch (2) 2
Finnish (2) 2
Swedish (2) 2
Hebrew (1) 1
Lithuanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 04/2017, Volume 76, Issue 4, pp. 736 - 744
New molecularly targeted therapeutics are changing dermatologic therapy. Janus kinase–signal transducer and activator of transcription... 
Dermatology | JAK-STAT | psoriasis | baricitinib | vitiligo | atopic dermatitis | JAK inhibitor | ruxolitinib | alopecia areata | tofacitinib | Life Sciences & Biomedicine | Science & Technology | Pyrazoles - therapeutic use | Dermatitis, Atopic - enzymology | Humans | Dermatologic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Dermatologic Agents - adverse effects | Anti-Inflammatory Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Pyrroles - adverse effects | Vitiligo - drug therapy | Pyrroles - therapeutic use | Pyrazoles - adverse effects | Psoriasis - drug therapy | Vitiligo - enzymology | Azetidines - adverse effects | Alopecia Areata - enzymology | Skin Diseases - drug therapy | Clinical Trials as Topic | Dermatologic Agents - classification | Janus Kinases - antagonists & inhibitors | Dermatitis, Atopic - drug therapy | Alopecia Areata - drug therapy | Azetidines - therapeutic use | Signal Transduction - drug effects | Sulfonamides - therapeutic use | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Psoriasis - enzymology | Skin Diseases - enzymology | Medical colleges | Psoriasis | Atopic dermatitis | Formulae, receipts, prescriptions | Dermatologic agents | Pharmaceutical industry | Tyrosine | Interleukins | Interferon | Biological response modifiers | T cells | Index Medicus | Tofacitinib
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 04/2017, Volume 76, Issue 4, pp. 745 - 753.e19
.... Objective Our aim was to systematically review the available data on the use of JAK inhibitors in cutaneous diseases... 
Dermatology | dermatology | psoriasis | baricitinib | vitiligo | atopic dermatitis | ruxolitinib | alopecia areata | JAK inhibitors | graft versus host disease | tofacitinib | Life Sciences & Biomedicine | Science & Technology | Pyrazoles - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Dermatologic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Dermatologic Agents - adverse effects | Anti-Inflammatory Agents - adverse effects | Antineoplastic Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Pyrroles - adverse effects | Pyrroles - therapeutic use | Pyrazoles - adverse effects | Drug Eruptions - etiology | Psoriasis - drug therapy | Azetidines - adverse effects | Alopecia Areata - enzymology | Skin Diseases - drug therapy | Randomized Controlled Trials as Topic | Janus Kinases - antagonists & inhibitors | Alopecia Areata - drug therapy | Azetidines - therapeutic use | Signal Transduction - drug effects | Sulfonamides - therapeutic use | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Psoriasis - enzymology | Skin Diseases - enzymology | Mutual fund industry | Lupus | Psoriasis | Dermatologic agents | Arthritis | Non-Hodgkin's lymphomas | T cells | Rheumatoid factor | Atopic dermatitis | Analysis | Formulae, receipts, prescriptions | Respiratory tract diseases | Skin | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2017, Volume 376, Issue 7, pp. 652 - 662
Journal Article